Response to the ACMD recommendation: Epidyolex
Monday, 4 May 2020 10:50
|
Letter responding to the ACMD on Epidyolex scheduling and
definition under the Misuse of Drugs Regulations 2001 Details On
the 29 January 2020, the Advisory Council on the Misuse of Drugs
(ACMD) recommended placing Epidyolex (a cannabis-based
medicine) under Schedule 5 of the Misuse of Drugs Regulations 2001.
This letter is a response to the ACMD recommendation from the
Minister of State for Fire and Policing....Request free trial
|